The Trump administration released its much-anticipated National Security Strategy this week. CFR convened six of its experts ...

The coming era of biosecurity will demand a broader and more adaptive approach as AI, powerful biological engineering ...

A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes (T2D) or ...

RAISE focuses on improving race and ethnicity data collection to address healthcare disparities and unmet medical needs. The ...

Three major nuclear reactor accidents—Three Mile Island (1979 in the United States), Chernobyl (1986 in Ukraine, then part of the Soviet Union), and Fukushima Dai-ichi (2011 in Japan)—significantly ...

Clinicians and health system leaders met in Portland, Oregon, on October 21, 2025, to discuss the evolving options for treating Alzheimer disease and multiple sclerosis.

The current poverty level – inflation adjusted from that 1963 base – is $31,200 for a family of four. I think we can all ...

Consequently, con artists change their techniques to respond to changing consumer awareness, says the latest threat ...

Challenges in clinical trials are unique to each therapeutic area, whether patient recruitment or regulatory compliance. For example, oncology trials require precise endpoint definitions, while ...

As buildings face tougher climate demands, green certifications are shifting from checklists to real performance. Here's how ...

Pfizer Inc. (NYSE: PFE) today presented results from the Phase 3 BASIS study (NCT03938792) evaluating HYMPAVZI® (marstacimab) for adults and adolescents living with hemophilia A or B with inhibitors.

This potentially valuable cross-sectional longitudinal study leverages high-definition transcranial direct current stimulation to the left dorsolateral prefrontal cortex to examine its effect on ...